शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEBOSTON COMMERCE LIMITED· Healthcare ServicesHighNeutral
Announced Fri, 14 Aug, 2026 · 16:57 IST

New CFO and Whole-Time Director appointed at Boston Commerce

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹4.49
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.1% vs market
Healthcare Service Provider peers, median of 27sector+0.7%-0.7% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+0.1-0.1+0.7-0.7
Next day
+9.1+0.5+8.6+1.6+7.6
2d
+9.1-0.1+9.2-0.8+10.0
3d
+15.6+0.4+15.2-0.2+15.8
4d
+4.2+0.7+3.5-0.5+4.7
5d
—+0.9—+1.8—
1w
+4.7+1.1+3.6+1.9+2.8
15d
+4.2+1.6+2.6+1.9+2.3
1m
+33.2-0.7+33.9+4.1+29.1
2m
+128.1-3.2+131.3-4.2+132.2
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Boston Commerce Limited appointed Mrs. Archana Chaitanya Pandya as Additional Director, Whole-Time Director for a 5-year term and Chief Financial Officer, effective 14 August 2026. She holds a B.Com degree with experience in finance, accounting and administration. She is not related to any existing director and is not debarred. The appointment is subject to shareholder approval.

Likely market impact

Fills the CFO and WTD roles. Routine KMP change needing shareholder approval. Neutral near-term; check for any previous CFO exit disclosure.